Vaidya VS - Search Results

1

A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the Coronavirus Disease 2019 Pandemic.

Fader KA, Zhang J, Menetski JP, Thadhani RI, Antman EM, Friedman GS, Ramaiah SK, Vaidya VS. Fader KA, et al. Among authors: vaidya vs. J Pharmacol Exp Ther. 2021 Jan;376(1):12-20. doi: 10.1124/jpet.120.000204. Epub 2020 Oct 28. J Pharmacol Exp Ther. 2021. PMID: 33115823 Free PMC article. Review.

2

Industry Perspective on Biomarker Development and Qualification.

Gerlach CV, Derzi M, Ramaiah SK, Vaidya VS. Gerlach CV, et al. Among authors: vaidya vs. Clin Pharmacol Ther. 2018 Jan;103(1):27-31. doi: 10.1002/cpt.919. Epub 2017 Nov 16. Clin Pharmacol Ther. 2018. PMID: 29143971

3

Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species.

Fader KA, Pardo ID, Kovi RC, Somps CJ, Wang HH, Vaidya VS, Ramaiah SK, Sirivelu MP. Fader KA, et al. Among authors: vaidya vs. Mol Ther Methods Clin Dev. 2022 Mar 28;25:264-277. doi: 10.1016/j.omtm.2022.03.017. eCollection 2022 Jun 9. Mol Ther Methods Clin Dev. 2022. PMID: 35505662 Free PMC article.

4

Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans.

Llewellyn HP, Vaidya VS, Wang Z, Peng Q, Hyde C, Potter D, Wang J, Zong Q, Arat S, Martin M, Masek-Hammerman K, Warner R, Johnson K, Kullak-Ublick GA, Aithal GP, Dear JW, Ramaiah SK. Llewellyn HP, et al. Among authors: vaidya vs. Toxicol Sci. 2021 Apr 27;181(1):23-34. doi: 10.1093/toxsci/kfab003. Toxicol Sci. 2021. PMID: 33483742

5

Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial.

Wagner KR, Guglieri M, Ramaiah SK, Charnas L, Marraffino S, Binks M, Vaidya VS, Palmer J, Goldstein R, Muntoni F. Wagner KR, et al. Among authors: vaidya vs. Biomark Med. 2021 Oct;15(15):1389-1396. doi: 10.2217/bmm-2021-0222. Epub 2021 Sep 17. Biomark Med. 2021. PMID: 34533053 Free article. Clinical Trial.

6

MicroRNAs and drug-induced kidney injury.

Pavkovic M, Vaidya VS. Pavkovic M, et al. Among authors: vaidya vs. Pharmacol Ther. 2016 Jul;163:48-57. doi: 10.1016/j.pharmthera.2016.03.016. Epub 2016 Apr 25. Pharmacol Ther. 2016. PMID: 27126472 Free PMC article. Review.

7

Upregulated promitogenic signaling via cytokines and growth factors: potential mechanism of robust liver tissue repair in calorie-restricted rats upon toxic challenge.

Apte UM, Limaye PB, Ramaiah SK, Vaidya VS, Bucci TJ, Warbritton A, Mehendale HM. Apte UM, et al. Among authors: vaidya vs. Toxicol Sci. 2002 Oct;69(2):448-59. doi: 10.1093/toxsci/69.2.448. Toxicol Sci. 2002. PMID: 12377994

8

MicroRNAs in injury and repair.

Gerlach CV, Vaidya VS. Gerlach CV, et al. Among authors: vaidya vs. Arch Toxicol. 2017 Aug;91(8):2781-2797. doi: 10.1007/s00204-017-1974-1. Epub 2017 May 13. Arch Toxicol. 2017. PMID: 28501916 Free PMC article. Review.

9

RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis.

Craciun FL, Bijol V, Ajay AK, Rao P, Kumar RK, Hutchinson J, Hofmann O, Joshi N, Luyendyk JP, Kusebauch U, Moss CL, Srivastava A, Himmelfarb J, Waikar SS, Moritz RL, Vaidya VS. Craciun FL, et al. Among authors: vaidya vs. J Am Soc Nephrol. 2016 Jun;27(6):1702-13. doi: 10.1681/ASN.2015020225. Epub 2015 Oct 8. J Am Soc Nephrol. 2016. PMID: 26449608 Free PMC article.

10

Biomarkers of acute kidney injury.

Vaidya VS, Ferguson MA, Bonventre JV. Vaidya VS, et al. Annu Rev Pharmacol Toxicol. 2008;48:463-93. doi: 10.1146/annurev.pharmtox.48.113006.094615. Annu Rev Pharmacol Toxicol. 2008. PMID: 17937594 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters